Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Caldéraro, Haeryoung Kim, Narmin Ghaffari Laleh et al.|Nature Communications|2023Cited by 76
Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and cliniciansSophie Outh-Gauer, Cécile Badoual, Thomas Denize et al.|Cancer Treatment Reviews|2018Cited by 71
Stroma-driven intertumoral and intratumoral heterogeneity of PD-L1 expression in cholangiocarcinoma: Implications for biomarker development and prognostic evaluationAnna Saborowski, Arndt Vogel, Simon Peters et al.|Hepatology|2026Cited by 1